-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Initiates Coverage On Forte Biosciences with Buy Rating, Announces Price Target of $75

Benzinga·08/18/2025 13:03:29
Listen to the news
Guggenheim analyst Yatin Suneja initiates coverage on Forte Biosciences (NASDAQ:FBRX) with a Buy rating and announces Price Target of $75.